News
02-15-2024, 02:45 PM
A novel three-drug combination achieved notable responses in patients with advanced HER2-negative breast cancer, according to new research directed by investigators from the Johns Hopkins Kimmel Cancer Center.
More... (https://www.news-medical.net/news/20240214/Novel-three-drug-combo-shows-promise-in-advanced-HER2-negative-breast-cancer-treatment.aspx)
More... (https://www.news-medical.net/news/20240214/Novel-three-drug-combo-shows-promise-in-advanced-HER2-negative-breast-cancer-treatment.aspx)